2 mL urine using Aptima® Urine Specimen Collection Kit
Target Capture, TMA: Transcription-Mediated Amplification (NAT) and Dual Kinetic Assay (DKA). All specimens testing positive in the screening assay are confirmed in a confirmatory assay targeting different regions of the nucleic acid of the organism. This assay has been cleared for use by the FDA on some specimen types. For other specimen types where this assay has not been cleared or approved by the FDA; Pathology, Inc. has validated this test and determined its performance characteristics. This individual validation has not been cleared nor approved by the FDA.
Urine in sterile urine container must be transferred to Aptima® Urine Collection Kit within 24hrs of collection.
As an aid in the diagnosis of Chlamydia infection.